Kevin D. Nelson, Ph.D.
Founder & Chief Scientific Officer
Dr. Kevin Nelson received his Ph.D. from The University of Texas Southwestern Medical Center at Dallas under the direction of Dr. Robert Eberhart. A faculty member in Biomedical Engineering at The University of Texas at Arlington (UTA), in 1996 he joined a team working on an NIH grant to develop a fiber-based, biodegradable vascular stent with the goal of delivering gene therapy to the vessel wall. Simultaneously working with Dr. Nathan Schwade to develop drug-loaded microspheres for improved wound healing, he eventually combined the drug-loading techniques of microspheres with the fiber for the biodegradable stent, and fiber-based drug delivery was born. Eventually patented, this technology has been the focus of Dr. Nelson’s professional life and the driver behind TissueGen, Inc.